76 related articles for article (PubMed ID: 1727381)
1. Altered p53 gene structure and expression in human epithelial cells after exposure to nickel.
Maehle L; Metcalf RA; Ryberg D; Bennett WP; Harris CC; Haugen A
Cancer Res; 1992 Jan; 52(1):218-21. PubMed ID: 1727381
[TBL] [Abstract][Full Text] [Related]
2. Nickel-induced alterations in human renal epithelial cells.
Haugen A; Maehle L; Mollerup S; Rivedal E; Ryberg D
Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):117-8. PubMed ID: 7843084
[TBL] [Abstract][Full Text] [Related]
3. Immortalization of normal human kidney epithelial cells by nickel(II).
Tveito G; Hansteen IL; Dalen H; Haugen A
Cancer Res; 1989 Apr; 49(7):1829-35. PubMed ID: 2924322
[TBL] [Abstract][Full Text] [Related]
4. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma.
Williams AC; Browne SJ; Yeudal WA; Paterson IC; Marshall CJ; Lane DP; Paraskeva C
Oncogene; 1993 Nov; 8(11):3063-72. PubMed ID: 8414507
[TBL] [Abstract][Full Text] [Related]
5. The human p53 gene mutated at position 249 per se is not sufficient to immortalize human liver cells.
Schleger C; Becker R; Oesch F; Steinberg P
Hepatology; 1999 Mar; 29(3):834-8. PubMed ID: 10051487
[TBL] [Abstract][Full Text] [Related]
6. Low incidence of point mutations detected in the p53 tumor suppressor gene from chemically induced rat renal mesenchymal tumors.
Weghorst CM; Dragnev KH; Buzard GS; Thorne KL; Vandeborne GF; Vincent KA; Rice JM
Cancer Res; 1994 Jan; 54(1):215-9. PubMed ID: 8261441
[TBL] [Abstract][Full Text] [Related]
7. A possible role for human papillomaviruses and c-myc, c-Ha-ras, and p53 gene alterations in malignant cutaneous lesions from renal transplant recipients.
Pelisson I; Soler C; Chardonnet Y; Euvrard S; Schmitt D
Cancer Detect Prev; 1996; 20(1):20-30. PubMed ID: 8907200
[TBL] [Abstract][Full Text] [Related]
8. Influence of exogenous ras and p53 on P-glycoprotein function in immortalized rodent fibroblasts.
Kopnin BP; Stromskaya TP; Kondratov RV; Ossovskaya VS; Pugacheva EN; Rybalkina EY; Khokhlova OA; Chumakov PM
Oncol Res; 1995; 7(6):299-306. PubMed ID: 8527864
[TBL] [Abstract][Full Text] [Related]
9. p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines.
Lehman TA; Bennett WP; Metcalf RA; Welsh JA; Ecker J; Modali RV; Ullrich S; Romano JW; Appella E; Testa JR
Cancer Res; 1991 Aug; 51(15):4090-6. PubMed ID: 1855224
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
[TBL] [Abstract][Full Text] [Related]
11. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.
Wagata T; Shibagaki I; Imamura M; Shimada Y; Toguchida J; Yandell DW; Ikenaga M; Tobe T; Ishizaki K
Cancer Res; 1993 Feb; 53(4):846-50. PubMed ID: 8094033
[TBL] [Abstract][Full Text] [Related]
12. A new human acute monocytic leukemia cell line SHI-1 with t(6;11)(q27;q23), p53 gene alterations and high tumorigenicity in nude mice.
Chen S; Xue Y; Zhang X; Wu Y; Pan J; Wang Y; Ceng J
Haematologica; 2005 Jun; 90(6):766-75. PubMed ID: 15951289
[TBL] [Abstract][Full Text] [Related]
13. Altered chromosomal methylation patterns accompany oncogene-induced transformation of human bronchial epithelial cells.
Vertino PM; Spillare EA; Harris CC; Baylin SB
Cancer Res; 1993 Apr; 53(7):1684-9. PubMed ID: 8453642
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of a new human acute myelocytic leukemia cell line SH-2 with a loss of Y chromosome, a derivative chromosome 16 resulting from an unbalanced translocation between chromosomes 16 and 17, monosomy 17, trisomy 19, and p53 alteration.
Qiu H; Xue Y; Zhang J; Pan J; Dai H; Wu Y; Wang Y; Chen S; Wu D
Exp Hematol; 2008 Nov; 36(11):1487-95. PubMed ID: 18715689
[TBL] [Abstract][Full Text] [Related]
15. Indistinct cell cycle checkpoint after u.v. damage in H-ras-transformed mouse liver cells despite normal p53 gene expression.
Kadohama T; Tsuji K; Ogawa K
Oncogene; 1994 Oct; 9(10):2845-52. PubMed ID: 8084590
[TBL] [Abstract][Full Text] [Related]
16. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
Zongaro S; de Stanchina E; Colombo T; D'Incalci M; Giulotto E; Mondello C
Cancer Res; 2005 Dec; 65(24):11411-8. PubMed ID: 16357149
[TBL] [Abstract][Full Text] [Related]
17. Amplification of the Ect2 proto-oncogene and over-expression of Ect2 mRNA and protein in nickel compound and methylcholanthrene-transformed 10T1/2 mouse fibroblast cell lines.
Clemens F; Verma R; Ramnath J; Landolph JR
Toxicol Appl Pharmacol; 2005 Aug; 206(2):138-49. PubMed ID: 15967202
[TBL] [Abstract][Full Text] [Related]
18. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.
Stratton MR; Moss S; Warren W; Patterson H; Clark J; Fisher C; Fletcher CD; Ball A; Thomas M; Gusterson BA
Oncogene; 1990 Sep; 5(9):1297-301. PubMed ID: 2216456
[TBL] [Abstract][Full Text] [Related]
19. Investigating DNA adduct-targeted mutagenicity of tamoxifen: preferential formation of tamoxifen-DNA adducts in the human p53 gene in SV40 immortalized hepatocytes but not endometrial carcinoma cells.
Besaratinia A; Pfeifer GP
Biochemistry; 2005 Jun; 44(23):8418-27. PubMed ID: 15938631
[TBL] [Abstract][Full Text] [Related]
20. Gradual selection of a cellular clone presenting a mutation at codon 179 of the p53 gene during establishment of the immortalized human breast epithelial cell line HMT-3522.
Moyret C; Madsen MW; Cooke J; Briand P; Theillet C
Exp Cell Res; 1994 Dec; 215(2):380-5. PubMed ID: 7982476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
